K Pharma (TSE:4896) Issuance of Debt: 円0.00 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4896 K Pharma Inc TSE:4896
11 GF Score
Price 円812.00
! 1 Warning Sign
View Full Analysis

What is K Pharma Issuance of Debt?

K Pharma TSE:4896 +1.63% 11 Issuance of Debt is 円0.00 Mil as of Jun. 2026. GuruFocus rates TSE:4896 with a GF Score™ of 11/100. The stock has 1 warning sign investors should review.

K Pharma's Issuance of Debt for the three months ended in Jun. 2026 was 円0.00 Mil.

K Pharma's Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2026 was 円0.00 Mil.

K Pharma Issuance of Debt Related Terms

K Pharma Issuance of Debt Historical Data

* Premium members only.

The historical data trend for K Pharma's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

K Pharma Issuance of Debt Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Issuance of Debt
0.00 0.00 0.00 0.00 1,495.98

K Pharma Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4896
11GF Score
K Pharma Inc TSE:4896
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

K Pharma Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of 円0.00 Mil mean?
K Pharma (TSE:4896) has a Issuance of Debt of 円0.00 Mil as of Jun. 2026. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on K Pharma and its competitors.
Is K Pharma's Issuance of Debt too high?
K Pharma's current Issuance of Debt is 円0.00 Mil. Overall, K Pharma has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does K Pharma's Issuance of Debt compare to VRTX and REGN?
K Pharma's Issuance of Debt of 円0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Biotechnology company?
A good Issuance of Debt depends on the Biotechnology industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on K Pharma and its competitors. K Pharma's current Issuance of Debt is 円0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is K Pharma stock overvalued right now?
K Pharma (TSE:4896) has a current Issuance of Debt of 円0.00 Mil. The current Issuance of Debt is 円0.00 Mil. K Pharma's overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For K Pharma (TSE:4896), the current Issuance of Debt is 円0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

K Pharma Business Description

Address 7-7-7 Roppongi, Tri-Seven Roppongi 8th Floor, Minato-ku, Tokyo, JPN, 106-0032
K Pharma Inc is a company involved in Research, development, manufacturing, sales, and marketing of pharmaceutical products and regenerative medicine products. It is involved in the study of iPs cells in regenerative medicine to treat neurological conditions such as cerebral infarction and SCI.
11GF Score

Get the complete analysis for TSE:4896

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円812.00
Price